An efficacy and safety comparing topical 5% azelaic acid versus 2% minoxidil solution in treatment of androgenetic alopecia in female: a randomized controlled trial
Phase 3
Recruiting
- Conditions
- female androgenetic alopecia
- Registration Number
- TCTR20180319001
- Lead Sponsor
- Institutional review and signing
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Female patients, older than 18 years of age, who were diagnosed with androgenetic alopecia.
- Patients have never been treated for at least 6 months prior to the study.
- Patients agree to participate in the research project and can complete the treatment throughout the period.
Exclusion Criteria
- People with congestive heart disease, such as anemia, diabetes, chronic alcoholism, previous
gastrointestinal surgery, short bowel syndrome, Crohn's disease, digestive disorder, hypo / hyperthyroidism, autoimmune disease
- Patients with other skin lesions in the treatment area, such as psoriasis, fungal infection on the scalp
- Patients with impaired mental status, including trichotillomania
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparative efficacy of 5% azelaic acid and 2% minoxidil solution in female androgenetic alopecia 6 months To evaluate the difference of hair density, hair shaft diameter
- Secondary Outcome Measures
Name Time Method To study the safety of 5% azelaic acid and 2% minoxidil solution 6 months history and physical examination every visits after applying the study's drug